Texas 2025 - 89th Regular

Texas Senate Bill SB1827

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to investigational stem cell treatment.

Impact

If enacted, SB 1827 would likely affect both healthcare providers and patients by clarifying the legal landscape for investigational treatments. Healthcare providers would need to comply with new regulations pertaining to the administering of these treatments, ensuring that they are conducted under stringent guidelines, including oversight by institutional review boards. By setting clear parameters for how these treatments can be offered, the bill aims to foster an environment where patients have access to innovative therapies while also protecting their rights and safety.

Summary

Senate Bill 1827 seeks to regulate investigational stem cell treatments within Texas, aiming to streamline the protocols surrounding such treatments and establish guidelines that ensure compliance with state and federal regulations. The bill specifically amends several sections of the Health and Safety Code, defining investigational stem cell treatments to include treatments using adult stem cells under investigation in clinical trials that have not yet received FDA approval for general use. This formalization represents a significant legislative push towards embracing advancements in stem cell research while maintaining regulatory oversight.

Contention

Notably, the bill introduces a formal consent process for patients undergoing investigational stem cell treatments, which may raise discussions around issues of medical ethics and patient autonomy. Critics might argue that the added bureaucratic layers could deter research initiatives or make access to potentially life-saving treatments more complex. Additionally, there may be concerns regarding the qualifications required for oversight boards and the implications of not requiring FDA approval at the time of treatment provision, which some advocates for consumer safety may find contentious.

Texas Constitutional Statutes Affected

Health And Safety Code

  • Chapter 1003. Adult Stem Cells
    • Section: New Section
    • Section: 059

Companion Bills

TX HB5147

Identical Relating to investigational stem cell treatment.

Previously Filed As

TX SB773

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HB638

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX SB1757

Relating to the treatment of and education on sickle cell disease and the sickle cell task force.

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB177

Relating to informed consent before provision of certain medical treatments and exemptions from COVID-19 vaccination requirements.

TX HB4624

Relating to gender modification procedures and treatments for certain minors; providing a civil penalty.

TX SB426

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

TX HB81

Relating to informed consent before provision of certain medical treatments and exemptions from COVID-19 vaccination requirements.

Similar Bills

No similar bills found.